Remote Ischemic Preconditioning Does Not Improve the Six Minutes Walk Test Performance in Chronic Heart Failure...

Area of Science:

• Cardiovascular Medicine
• Exercise Physiology
• Rehabilitation Science

Background:

• Remote ischemic preconditioning (RIPC) involves cycles of ischemia and reperfusion to induce protective effects.
• Previous studies suggest RIPC enhances performance in healthy individuals' time-trial events.
• The efficacy of RIPC in improving functional capacity for heart failure (HF) patients remains unclear.

Purpose of the Study:

• To evaluate the impact of RIPC on the functional capacity of HF patients.
• To assess changes in metabolic and hemodynamic responses during a six-minute walk test (6MWT) following RIPC.

Main Methods:

• A randomized crossover study involving 15 HF patients.
• Intervention consisted of 4 cycles of 5-minute upper arm ischemia (RIPC) or a sham procedure.
• Functional capacity was measured by the 6MWT, with secondary measures including gas exchange and muscle oxygen saturation (smO2).

Main Results:

• No significant difference in 6MWT distance between RIPC (347 ± 63 m) and sham (352 ± 65 m) (p = 0.514).
• Relative oxygen uptake, heart rate, respiratory exchange ratio, smO2, and ventilation showed no significant changes between interventions.
• HF patients tolerated the RIPC procedure well.

Conclusions:

• RIPC did not significantly improve functional capacity or physiological parameters in this cohort of HF patients.
• Further research is needed to explore potential benefits or alternative protocols of RIPC in cardiovascular populations.
• While safe, RIPC demonstrated no functional benefit for HF patients in this study.